Jun 18, 2020
Almirall Announces FDA Approval Of Updated Label For Seysara® (Sarecycline) Tablets
Jun 16, 2020
Whole in One: Treat Enlarged Pores and Give Your Skin an Overall Boost
Jun 10, 2020
Dermata Announces Positive Results from its Phase 2b Clinical Trial of Once Weekly Topical Application of DMT310 for the Treatment of Moderate to Severe Acne Vulgaris
May 29, 2020
Menlo Therapeutics Receives FDA Approval of ZILXI(TM) (minocycline) topical foam, 1.5%, the First Topical Minocycline Treatment for Rosacea
May 07, 2020
Acne Market Review 2016-2019 and Forecast to 2024
May 07, 2020
Accure Receives CE Mark Approval for First-Ever 1726nm Laser Platform to treat Acne
Apr 09, 2020
Global Dermatologicals Market is Expected to Reach $36.2 Billion by 2026
Apr 09, 2020
Hoth Therapeutics Commences Next Phase of VNLG-152 Study
Mar 26, 2020
COSMEDIX Announces the Launch of Clean, Clinical Spot Treatment for Acne-Prone Skin
Mar 10, 2020
Advisory - Unauthorized skin lightening products seized from Blue Sky Supermarket: products may pose serious health risks
Mar 06, 2020
The anti-acne serum market size was valued at $810.2 million in 2018, and is expected to reach $1.5 billion by 2026, registering a CAGR of 7.90% from 2019 to 2026
Feb 27, 2020
Leading Laser Hair Removal Clinic in Toronto Updates Skincare Offering
Feb 11, 2020
Dermata Therapeutics Announces Completion of Enrollment in a Phase 2b Trial of Once Weekly Topical Application of DMT310 for the Treatment of Moderate to Severe Acne Vulgaris
Feb 04, 2020
Fighting Acne: A New Approach Sourced From Viruses
Jan 31, 2020
Candela® And MT.DERM Sign Exclusive Collaboration Agreement
Jan 28, 2020
Introducing ARMADA(TM) UV - Smartphone-based skin follicular oil / sebum image detection technology developed by Galileo Group, Inc.
Jan 14, 2020
Foamix Announces AMZEEQ(TM) (minocycline) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S.
Jan 13, 2020
Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Data On ARAZLO(TM) (tazarotene) Lotion, 0.045% In The Journal Of Drugs In Dermatology (JDD)
Jan 09, 2020
Foamix Announces AMZEEQ(TM) (minocycline) Topical Foam Available in Pharmacies Nationwide on January 13th for the Treatment of Moderate to Severe Acne
Jan 09, 2020
Gladskin Launches in USA - Micreos Scaling up to Deliver Award Winning Technology Worldwide